Medtronic plc MDT presented new clinical and real-world data on the MiniMed 780G system at the 83rd American Diabetes Association Scientific Sessions. In April, the FDA approved Medtronic's MiniMed ...

Medtronic plc (NYSE:MDT) is one of the 14 Tech Stocks to Sell Now According to Ken Fisher. On September 2, 2025, Medtronic plc (NYSE:MDT) announced that the FDA cleared its SmartGuard algorithm as an ...

Two years after submitting the latest version of its insulin pump technology for FDA approval—and three years after it was first made available in Europe—Medtronic has finally secured the agency’s ...

The FDA approved Medtronic's latest MiniMed insulin pump system, the company announced late last week. Indicated for individuals with type 1 diabetes ages 7 and older, the MiniMed 780G system pairs ...

The MiniMed 780G system has been approved for children aged 7 years and up with type 1 diabetes (T1D), according to Medtronic. The FDA has approved Medtronic’s MiniMed 780G system with Guardian 4 ...

As Medtronic begins rolling out a recently FDA-cleared diabetes management system combining its MiniMed 780G insulin pump and Abbott’s Instinct glucose sensor, the medtech giant has launched a new ...

Medtronic kicked off Diabetes Awareness Month with news that its MiniMed 780G system for people living with type 1 diabetes has received a regulatory license from Health Canada. The company touts that ...

Medtronic's diabetes business was a sweet spot in the company's fiscal first quarter of 2024. After FDA approved the company's MiniMed 780G system with the Guardian 4 sensor in April, analysts and ...